People with cold agglutinin disease (CAD) show signs of red blood cell destruction year round, not just when the weather is cold, a new study highlights. These findings suggest that CAD patients should be closely monitored at all times, regardless of season, according to researchers. The study, “Complement-mediated hemolysis persists year round in patients with cold agglutinin disease,” was published in the journal Transfusion. CAD is an autoimmune disorder caused by self-targeting antibodies called cold…

You must be logged in to read/download the full post.